STAT+: Roger Perlmutter, former Merck R&D head, becomes CEO of super-microscopy startup
Roger Perlmutter, previously the head of research at Merck, said Wednesday he will become the CEO of a startup that is using Nobel Prize-winning microscope technology that can pinpoint the location of individual molecules within human cells as a way to invent new medicines.
The company, Eikon Therapeutics of Hayward, Calif., also announced that it has raised $148 million from The Column Group and other investors including Foresite Capital, Innovation Endeavors, and Lux Capital.
Continue to STAT+ to read the full story…
